TTD | Drug: D0GR2H

Drug General Information
Drug ID	D0GR2H
Former ID	DNC014587
Drug Name	BMY-44621
Drug Type	Small molecular drug
Indication	Discovery agent		Terminated	[545449]
Formula	C19H27N5O3
Canonical SMILES	C1CC(N(C1)C(=O)CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C=O
InChI	1S/C19H27N5O3/c20-19(21)22-10-4-8-15(13-25)23-18(27)16-9-5-11-24(16)17(26)12-14-6-2-1-3-7-14/h1-3,6-7,13,15-16H,4-5,8-12H2,(H,23,27)(H4,20,21,22)/t15-,16-/m0/s1
InChIKey	FWMLVCYBCSOEBZ-HOTGVXAUSA-N
PubChem Compound ID	11740077
Target and Pathway
Target(s)	Trypsin	Target Info	Inhibitor	[551325]
KEGG Pathway	Neuroactive ligand-receptor interaction
	Pancreatic secretion
	Protein digestion and absorption
	Influenza A
Reactome	Activation of Matrix Metalloproteinases
Reactome	Cobalamin (Cbl, vitamin B12) transport and metabolism
WikiPathways	Activation of Matrix Metalloproteinases
References
Ref 545449	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003308)
Ref 551325	Design and synthesis of conformationally constrained arginal thrombin inhibitors, Bioorg. Med. Chem. Lett. 7(17):2205-2210 (1997).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information